0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Cutaneous T-cell Lymphoma

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
Brentuximab as a Treatment for CD30+ Mycosis Fungoides and Sézary Syndrome
Tarun Mehra, MD; Kristian Ikenberg, MD; Rudolf Maria Moos, MD; et al.
JAMA Dermatology
Observation  | 
Cutaneous Hemophagocytosis After Alemtuzumab Injection in a Patient With Sézary Syndrome
Sarah I. Jawed, BA; Klaus Busam, MD; Xuan Wang, MD, PhD; et al.
JAMA Dermatology
Original Investigation  | 
Outcomes After Diagnosis of Mycosis Fungoides and Sézary Syndrome Before 30 Years of Age:  A Population-Based Study
Weiyun Z. Ai, MD, PhD; Theresa H. Keegan, PhD, MS; David J. Press, MPhil; et al.
JAMA Dermatology
Research Letter  | 
Alemtuzumab Therapy for Leukemic Cutaneous T-Cell Lymphoma:  Diffuse Erythema as a Positive Predictor of Complete Remission
Rei Watanabe, MD, PhD; Jessica E. Teague, PhD; David C. Fisher, MD; et al.